Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

This publication has 18 references indexed in Scilit:

• The ‘Utility’ of the Visual Analog Scale in Medical Decision Making and Technology Assessment: Is It an Alternative to the Time Trade-off?
  International Journal of Technology Assessment in Health Care, 1996
• Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months
  European Journal Of Cancer, 1993
• Cox regression models for quality adjusted survival analysis
  Statistics in Medicine, 1993
• Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast Cancer
  New England Journal of Medicine, 1991
• “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
  European Journal of Cancer and Clinical Oncology, 1991
• Quality adjusted survival analysis
  Statistics in Medicine, 1990
• Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer
  The Lancet, 1990
• Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer
  New England Journal of Medicine, 1987
• Assessment of response to therapy in advanced breast cancer
  Published by Elsevier ,1978
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958